andrew huberman glp 1 explains why GLP-1 medications could have the potential to dramatically reduce obesity. The science is evolving, and the conversation is bigger than weight loss alone. What's your take? 👇 #AndrewHuberman # By Increasing GLP-1, Yerba Mate

Animals were treated with DOX (8 mg/kg) once per week for 4 weeks, with ultrasound imaging every week to assess parameters of ( A ) left ventricular structure and ( B ) cardiac function

One promising class comprises sphingosine-1-phosphate (S1P) analogues such as fingolimod (FTY-720) [125, 126]

At least in mice, ACLY deletion 6 or bempedoic acid 40 strongly suppresses glucose-dependent hepatic de novo lipogenesis, suggesting that ACLY is a dominant mechanism for glucose-dependent de novo lipogenesis in the liver, although acetate can sustain lipogenesis in the absence of ACLY 6

Quicksilver Scientific is an American manufacturer of supplements, whose focus is the best possible bioavailability

IGFs and their receptors The physiological and pathological functions of IGF are largely mediated by its receptors